Literature DB >> 26482365

Clinical Usefulness of 5-FU Metabolic Enzymes as Predictive Markers of Response to Chemotherapy in Colorectal Cancer.

Kohei Shigeta1, Yoshiyuki Ishii2, Hirotoshi Hasegawa3, Koji Okabayashi3, Yuko Kitagawa3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26482365     DOI： 10.1007/s00268-015-3286-z

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  5 in total

1.  miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation.

Authors:  Valentina Boni; Nerea Bitarte; Ion Cristobal; Ruth Zarate; Javier Rodriguez; Evaristo Maiello; Jesus Garcia-Foncillas; Eva Bandres
Journal:  Mol Cancer Ther       Date:  2010-07-20       Impact factor: 6.261

2.  MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.

Authors:  Cristina Caramés; Ion Cristóbal; Víctor Moreno; Laura del Puerto; Irene Moreno; María Rodriguez; Juan P Marín; Andrea V Correa; Roberto Hernández; Víctor Zenzola; Tatiana Hernández; Ana León; José I Martín; Paloma Sánchez-Fayos; Damián García-Olmo; Federico Rojo; Ajay Goel; María J Fernandez-Aceñero; Jesús García-Foncillas
Journal:  Int J Colorectal Dis       Date:  2015-05-08       Impact factor: 2.571

3.  Association of right-sided tumors with high thymidine phosphorylase gene expression levels and the response to oral uracil and tegafur/leucovorin chemotherapy among patients with colorectal cancer.

Authors:  Sotaro Sadahiro; Toshiyuki Suzuki; Akira Tanaka; Kazutake Okada; Hideki Nagase; Junji Uchida
Journal:  Cancer Chemother Pharmacol       Date:  2012-06-30       Impact factor: 3.333

4.  Evaluation of 5-fluorouracil metabolic enzymes as predictors of response to adjuvant chemotherapy outcomes in patients with stage II/III colorectal cancer: a decision-curve analysis.

Authors:  Kohei Shigeta; Yoshiyuki Ishii; Hirotoshi Hasegawa; Koji Okabayashi; Yuko Kitagawa
Journal:  World J Surg       Date:  2014-12       Impact factor: 3.352

5.  Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients.

Authors:  A Paradiso; G Simone; S Petroni; B Leone; C Vallejo; J Lacava; A Romero; M Machiavelli; M De Lena; C J Allegra; P G Johnston
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640
  5 in total
  1 in total

1.  Oxymatrine reverses 5-fluorouracil resistance by inhibition of colon cancer cell epithelial-mesenchymal transition and NF-κB signaling in vitro.

Authors:  Li Liang; Jun Wu; Jie Luo; Li Wang; Zu Xuan Chen; Cheng Long Han; Ting Qing Gan; Jie An Huang; Zheng Wen Cai
Journal:  Oncol Lett       Date:  2019-11-13       Impact factor: 2.967
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.